Major funding bodies supporting our research:
- Parkinson’s UK is the largest charity funder of Parkinson’s research in the UK. So far, they have invested just under £70million in ground breaking research.
They fund research to advance the understanding of Parkinson’s and what causes it.
The research also focuses on finding new and better treatments to make life easier for people living with Parkinson’s.
They also keen to fund research that improves quality of life in the shorter term.
PUK have funded of our many projects over the years and in particular our longitudinal studies in PD as well as various other projects looking at more basic aspects of PD.
- FP7 was the European Union’s Research and Innovation funding programme for 2007-2013. This funding has supported one of the major ongoing studies running here, TransEUro, as well as Neurostemcell Repair.
- NeuroStemcellRepair (European stem cell consortium for neural cell replacement, reprogramming and functional brain repair) is a 4-year FP7 European Union funded Project which is led by Coordinator Prof. Elena Cattaneo – University of Milan and Deputy Coordinator Prof. Ernest Arenas – Karoliska Institutet. NeuroStemcellrepair, is formed to create a world-leading consortium that aims at taking human stem cells through the final steps toward clinical application in cell replacement therapy for neurological disorders. Including Parkinson’s and Huntington’s Disease.
- The Cure Parkinson’s Trust was founded in 2005, the charity’s ethos has evolved through a combination of four key elements; effective communication, passion, a real sense of urgency and passion. Cure-PD have supported our work including clinical trials and new therapies.
- Created in 1987, Rosetrees, a family Trust, uses venture philanthropy to support medical research. Their vision is to make a difference to humanity today and every day through medical research.
Rosetrees has given us many grants enabling us to undertake key studies looking at biomarkers and new therapies for PD and HD.
- The purpose of the Foundation is to support research projects in the field of chronic diseases and cancer, where the focus is on haematology and neurology.
Furthermore the Foundation supports private and public schools in their advancement on economy, research and entrepreneurship and have recently funded some of our work on sleep problems in HD.
- Addenbrooke’s Charitable Trust (ACT) is the only registered charity (no 1048868) dedicated to supporting innovation in patient care across Cambridge University Hospitals NHS Foundation Trust, which runs Addenbrooke’s Hospital. ACT have recently supported some of our work on PD.
- The Evelyn Trust is a grant-making charity supporting medical research and healthcare in the Cambridge area.
Established as a charity in 1920, the Evelyn Trust owned and managed the Evelyn Hospital in Cambridge. The funds support medical research and healthcare in the Cambridge area, seeking to benefit a broad range of projects that influence the development and delivery of healthcare services and other social services in the local community. Evelyn has funded work we are undertaking in PD and HD.
- CHDI Foundation is a privately-funded, not-for-profit biomedical research organization devoted to a single disease – Huntington’s disease. Their mission is to develop drugs that will slow the progression of Huntington’s disease and provide meaningful clinical benefit to patients as quickly as possible. They supported our work on sleep in HD.
- The vision of the NIHR is to improve the health and wealth of the nation through research. The mission is to provide a health research system in which the NHS supports outstanding individuals working in world-class facilities, conducting leading-edge research focused on the needs of patients and the public. The NIHR support large areas of our research including much of the infrastructure necessary to do this.
- The British Council was founded to create a friendly knowledge and understanding between the people of the UK and wider world by making a positive contribution to the countries we work with, and in doing so making a lasting difference to the UK’s security, prosperity and influence.
BIRAX (the Britain Israel Research and Academic Exchange Partnership) is a £10 million initiative of the British Embassy in Israel and the British Council in collaboration with the Pears Foundation and the UJIA. This funding was supported in conjunction with Parkinson’s UK.
- We are also grateful to the following for supporting our ongoing research:
Cambridge and Peterborough Foundation Trust